Learn More
Medchemexpress LLC [1,1'-Biphenyl]-3-propanoic acid, a-amino-2'-chloro-5-(phosphonomethyl)-, (aS)- | 174575-17-8 | 98.8% | 1 ML

Supplier: Medchemexpress LLC HY1305910MM/1ML
SDZ 220-581 is an orally active, potent, and competitive NMDA receptor antagonist with a pKi value of 7.7. In vivo studies have demonstrated that it dose-dependently protects against maximal electroshock seizures (MES), exhibiting a rapid onset and long duration of action.
- Orally active NMDA receptor antagonist
- Potent and competitive action
- pKi value of 7.7
- Protects against maximal electroshock seizures
- Rapid onset and long duration of action
- For research use only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.